Project cooperationUpdated on 20 January 2026
A structural approach to personalized medicine
Principal investigator - Academia at Bar Ilan University
Ramat Gan, Israel
About
We are experts in determining the atomic structure of biologically relevant protein-protein complexes, providing us with valuable insight into the structural basis of disease. We can apply this knowledge towards patient stratification and decisions on therapeutic pathways given the disease-causing mutation of a particular patient. We anticipate that in collaboration with physicians, cell biologists, computational/AI specialists and lab/organ-on-chip experts we can be an important contributor to a successful submission.
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Vladan Čokić
Head of Department of molecular oncology at Institute for Medical Research University of Belgrade
Belgrade, Serbia
Project cooperation
Expertise offer: structural mapping of protein-protein interactions in health and disease
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Jordan Chill
Principal investigator - Academia at Bar Ilan University
Ramat Gan, Israel
Project cooperation
NGS-based molecular diagnostics for lymphoproliferative diseases in Horizon Europe projects
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Silvia Angeletti
Full Professor Clinical Pathology and Head of Laboratory Unit at Fondazione Policlinico Universitario Campus Bio-Medico
Rome, Italy